A 52-year-old woman with a 15-year history of major depressive disorder presents to the psychiatry clinic. She has had three depressive episodes in the past 8 years, with the most recent remission 6 months ago. She reports persistent low mood, guilt, and difficulty concentrating. She lives alone since her husband died 3 years ago. She denies current suicidal ideation but states, 'Sometimes I wonder if my family would be better off without me.' On further questioning, she has no specific plan or intent. Her current medications are sertraline 150 mg daily and lorazepam 1 mg twice daily. Which of the following BEST characterizes her current suicide risk level?

Explanation

## Suicide Risk Assessment: Distinguishing Ideation Severity and Intent ### Clinical Presentation Analysis This patient presents with **passive suicidal ideation** (wondering if family would be better off) but **no active ideation, plan, or intent**. This distinction is critical in risk stratification. ### Suicide Ideation Spectrum | Type | Definition | This Patient | Risk Level | |---|---|---|---| | **Passive ideation** | Wish to be dead without intent to act | Present: 'wonder if better off' | Lower | | **Active ideation** | Thoughts of harming self with some intent | Absent | Higher | | **Ideation with plan** | Specific method and timeline identified | Absent | Much higher | | **Ideation with intent** | Determined to act; preparations made | Absent | Highest | ### Risk Factors Present (Static & Dynamic) **Static (non-modifiable):** - Female sex (higher attempt rate, though lower completion rate than males) - Age 52 (peak suicide risk in women is 40–60 years) - Recurrent major depression (3 episodes in 8 years) - Widowhood and social isolation **Dynamic (modifiable):** - Current depressive symptoms (low mood, guilt, concentration difficulty) - Benzodiazepine use (can disinhibit and increase impulsivity) - Suboptimal antidepressant response (on sertraline 150 mg but still symptomatic) ### Why This Is Moderate Risk **Key Point:** The presence of **passive ideation + multiple static risk factors + ongoing depressive symptoms + social isolation** = **moderate risk** requiring: 1. Close monitoring (regular follow-up, not hospitalization) 2. Psychotherapy intensification (CBT or IPT) 3. Medication optimization (consider augmentation or switch) 4. Safety planning and crisis resources **High-Yield:** Passive ideation alone does NOT mandate hospitalization, but it signals vulnerability and requires proactive intervention. The absence of plan and intent is reassuring but does not eliminate risk. **Clinical Pearl:** Many patients with moderate suicide risk are managed in outpatient settings with: - Frequent clinic visits (weekly or biweekly) - Psychotherapy (individual + group if available) - Medication review and optimization - Safety planning (remove access to lethal means, identify crisis contacts) - Family/social support engagement ### Management Algorithm for This Patient ```mermaid flowchart TD A[Passive ideation, no plan/intent]:::outcome --> B{Assess risk factors}:::decision B -->|Multiple static factors + ongoing depression| C[Moderate risk]:::outcome C --> D[Intensive outpatient management]:::action D --> E[Weekly psychotherapy]:::action D --> F[Medication optimization]:::action D --> G[Safety planning + crisis resources]:::action E --> H[Monitor for ideation escalation]:::decision H -->|Worsening| I[Hospitalization]:::urgent H -->|Stable/improving| J[Continue outpatient care]:::action ``` **Mnemonic: IS PATH WARM** (Interpersonal Needs Theory + Columbia Suicide Severity Rating Scale): - **I**deation (passive, not active) - **S**ubstance abuse (not present) - **P**anic attacks (not mentioned) - **A**ccess to means (assess; benzodiazepines are a concern) - **T**houghts of past attempts (not mentioned) - **H**opelessness (present: guilt, low mood) - **W**ithdrawn (social isolation: lives alone) - **A**nger/irritability (not prominent) - **R**ecklessness (not evident) - **M**ood (depressed) ### Medication Considerations **Warning:** Benzodiazepams (lorazepam) in the context of suicidality can increase disinhibition and impulsivity. Consider: - Tapering lorazepam gradually - Replacing with buspirone or hydroxyzine if anxiety is prominent - Optimizing antidepressant (consider augmentation with atypical antipsychotic or switch to different SSRI/SNRI) [cite:American Psychiatric Association Practice Guideline for the Assessment and Treatment of Patients with Suicidal Behaviors (2003); Kaplan & Sadock's Synopsis of Psychiatry 11e Ch 28]